Cardiovascular Medicine
-
Rate of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Use and the Number of COVID-19–Confirmed Cases and Deaths
This article has 4 authors:Reviewed by ScreenIT
-
Mortality and use of angiotensin-converting enzyme inhibitors in COVID 19 disease: a systematic review
This article has 1 author:Reviewed by ScreenIT
-
Renin–angiotensin–aldosterone system inhibitors and the risk of mortality in patients with hypertension hospitalised for COVID-19: systematic review and meta-analysis
This article has 8 authors:Reviewed by ScreenIT
-
Hypertension and renin-angiotensin system blockers are not associated with expression of angiotensin-converting enzyme 2 (ACE2) in the kidney
This article has 33 authors:Reviewed by ScreenIT
-
Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19
This article has 28 authors:Reviewed by ScreenIT
-
Association of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with risk of COVID‐19, inflammation level, severity, and death in patients with COVID‐19: A rapid systematic review and meta‐analysis
This article has 7 authors:Reviewed by ScreenIT
-
Association of Renin Angiotensin System Blockers with Outcomes in Patients with Covid-19: A Systematic Review and Meta-analysis
This article has 5 authors:Reviewed by ScreenIT
-
Antihypertensive medication uses and serum ACE2 levels
This article has 9 authors:Reviewed by ScreenIT
-
Cardiac Structural and Functional Characteristics in Patients with Coronavirus Disease 2019: A Serial Echocardiographic Study
This article has 11 authors:Reviewed by ScreenIT
-
NON-WHITE ETHNICITY, MALE SEX, AND HIGHER BODY MASS INDEX, BUT NOT MEDICATIONS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM ARE ASSOCIATED WITH CORONAVIRUS DISEASE 2019 (COVID-19) HOSPITALISATION: REVIEW OF THE FIRST 669 CASES FROM THE UK BIOBANK
This article has 8 authors:Reviewed by ScreenIT